Journal article
Efficacy and safety of direct oral anticoagulants compared with warfarin in antiphospholipid syndrome. Results of a multicenter retrospective cohort study
Abstract
Background: Direct oral anticoagulants (DOACs) have become firstline treatment for many thrombotic conditions, but their use in antiphospholipid syndrome (APS) patients remains controversial.
Objectives: This multicenter, retrospective cohort study conducted at Emory and McMaster University Medical Centers aimed to explore pattern of DOAC use among APS patients and compare the efficacy and safety of DOACs vs warfarin.
Authors
Elsebaie MAT; Wickham Z; DeBragga S; Fedewa S; Amgad M; Park JJ; Li A; Eshaghpour A; Li J; Crowther M
Journal
Research and Practice in Thrombosis and Haemostasis, Vol. 9, No. 4,
Publisher
Elsevier
Publication Date
5 2025
DOI
10.1016/j.rpth.2025.102856
ISSN
2475-0379